111
Participants
Start Date
June 30, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Anti-CD20 Monoclonal Antibody
Injection of monoclonal anti-CD20 antibody as immunomodulatory treatment of multiple sclerosis
Haukeland University Hospital
OTHER
Region Stockholm
OTHER_GOV